CSPC Pharmaceutical Group Ltd
HKEX:1093
Intrinsic Value
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. [ Read More ]
The intrinsic value of one CSPC Pharmaceutical Group Ltd stock under the Base Case scenario is 10.92 HKD. Compared to the current market price of 6.65 HKD, CSPC Pharmaceutical Group Ltd is Undervalued by 39%.
Valuation Backtest
CSPC Pharmaceutical Group Ltd
Run backtest to discover the historical profit from buying and selling CSPC Pharmaceutical Group Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
CSPC Pharmaceutical Group Ltd
| Current Assets | 26.7B |
| Cash & Short-Term Investments | 13.1B |
| Receivables | 9.8B |
| Other Current Assets | 3.8B |
| Non-Current Assets | 19.5B |
| Long-Term Investments | 4.7B |
| PP&E | 11.6B |
| Intangibles | 2.4B |
| Other Non-Current Assets | 805.9m |
| Current Liabilities | 10.2B |
| Accounts Payable | 2.4B |
| Other Current Liabilities | 7.8B |
| Non-Current Liabilities | 2.9B |
| Long-Term Debt | 107.1m |
| Other Non-Current Liabilities | 2.8B |
Earnings Waterfall
CSPC Pharmaceutical Group Ltd
|
Revenue
|
31.5B
CNY
|
|
Cost of Revenue
|
-9.3B
CNY
|
|
Gross Profit
|
22.2B
CNY
|
|
Operating Expenses
|
-14.5B
CNY
|
|
Operating Income
|
7.7B
CNY
|
|
Other Expenses
|
-1.8B
CNY
|
|
Net Income
|
5.9B
CNY
|
Free Cash Flow Analysis
CSPC Pharmaceutical Group Ltd
Profitability Score
Profitability Due Diligence
CSPC Pharmaceutical Group Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Score
CSPC Pharmaceutical Group Ltd's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
CSPC Pharmaceutical Group Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Score
CSPC Pharmaceutical Group Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
CSPC Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for CSPC Pharmaceutical Group Ltd is 9.71 HKD with a low forecast of 5.96 HKD and a high forecast of 13.65 HKD.
Shareholder Return
Price
CSPC Pharmaceutical Group Ltd
| Average Annual Return | 6.59% |
| Standard Deviation of Annual Returns | 21% |
| Max Drawdown | -56% |
| Market Capitalization | 79.2B HKD |
| Shares Outstanding | 11 875 940 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 24,746 full-time employees. The firm sells its products under the brand of CSPS. The firm has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The firm is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.
Contact
IPO
Employees
Officers
The intrinsic value of one CSPC Pharmaceutical Group Ltd stock under the Base Case scenario is 10.92 HKD.
Compared to the current market price of 6.65 HKD, CSPC Pharmaceutical Group Ltd is Undervalued by 39%.
You don't have any saved screeners yet
